Moreover, lycopene administration improved the intestinal barrier function and alleviated intestinal permeability, then reduced serum LPS levels and inhibited cardiovascular inflammation through inactivating the TLR4/NF-κB pathway, thereby inhibiting the progression of atherosclerosis. This evidence concerns the gene NFKB1 and inflammatory response.